Skip to main content

Table 6 Maternal and perinatal outcomes among women with and without advanced HIV disease

From: Burden, clinical presentation and risk factors of advanced HIV disease in pregnant Mozambican women

Variable

Advanced HIV disease

P-value

Yes N = 197

No N = 1337

At the delivery

Mother on ART

188 (96.4)

1298 (97.4)

0.549

Gestational age (weeks): median (IQR)

38 (36–40)

39 (37–40)

0.052

Type of delivery

Vaginal

187 (95.9)

1284 (96.4)

0.887

Caesarean

8 (4.1)

48 (3.6)

Preterm birth

20 (11.9)

99 (8.4)

0.187

Birthweight (grams): median (IQR)

3000 (2800–3275)

3000 (2800–3400)

0.079

Low birthweight (< 2500 g)

24 (12.4)

137 (10.3)

0.457

One month within delivery

  Mother on ART

195 (99.0)

1331 (99.6)

0.617

  Breastfeeding

191 (97.0)

1309 (97.9)

0.276

  Infant on cotrimoxazole prophylaxis

172 (88.7)

1210 (90.8)

0.401

  Neonate HIV infected

5 (3.9)

14 (1.6)

0.078

At the end of follow up perioda

  Variable

N = 349

N = 2109

 

  Deaths

4 (1.1)

11 (0.5)

0.309

  Period of death after ANC enrolment

0–5 months

2 (50.0)

4 (36.4)

0.821

6–11 months

1 (25.0)

1 (9.1)

12–17 months

0

1 (9.1)

18–23 months

0

1 (9.1)

 ≥ 24 months

1 (25.0)

4 (36.4)

  1. P-value for categorical variables is from Fisher exact test, and for continuous variables is from Mann–Whitney U test. Prematurity: child born at less than 37 weeks' gestation. IQR Interquartile range, ART Antiretroviral therapy, ANC Antenatal care. aUsing HDSS data base